Genomic profiling identifies alterations in TGFβ signaling through loss of TGFβ receptor expression in human renal cell carcinogenesis and progression View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-09-11

AUTHORS

John A Copland, Bruce A Luxon, Laila Ajani, Tapati Maity, Erica Campagnaro, Huiping Guo, Shauna N LeGrand, Pheroze Tamboli, Christopher G Wood

ABSTRACT

Renal cell carcinoma (RCC) is a major health issue. Whereas localized disease can be cured surgically, there is no effective therapy for metastatic disease. The development of an effective therapy will require an understanding of the pathways that are important in RCC carcinogenesis and progression. Using genomic profiling of patient-matched tissue, we have identified aberrations in the transforming growth factor β (TGFβ) signaling pathway in RCC. We observed loss of type III TGFβ receptor (TBR3) expression in all RCC samples. This suggests that TBR3 loss is an early event in RCC carcinogenesis and plays a sentinel role in the acquisition of a tumorigenic phenotype. We also observed subsequent loss of type II TGFβ receptor (TBR2) expression in metastatic RCCs. We propose that loss of TBR3 is necessary for RCC carcinogenesis, and that loss of TBR2 leads to acquisition of a metastatic phenotype. To this end, we have identified a human renal cell carcinoma line (UMRC6) that is representative of localized, nonmetastatic RCC, reflecting a loss of TBR3, but not TBR2 expression. Another cell line, UMRC3, is highly metastatic, having lost TBR3 and TBR2 expression. We demonstrate functional loss of TGFβ responsiveness in these cell lines as observed through phenotypic and transcriptional responsiveness to exogenous TGFβ. Restoring TBR2 and TBR3 expression in UMRC3 cells attenuates cell proliferation, completely restores TGFβ-mediated transcriptional responses, and completely blocks anchorage independent-growth: while restoration of TBR2 partially restores TGFβ-mediated signaling. Based on these data, we propose that dysregulation in TGFβ signaling, through stepwise loss in receptor expression, plays a prominent role in RCC carcinogenesis and progression. In addition, these studies unequivocably demonstrate a link between loss of TBR3 and a human disease. More... »

PAGES

8053-8062

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1206835

DOI

http://dx.doi.org/10.1038/sj.onc.1206835

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008229281

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12970754


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Renal Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Division", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Profiling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Serine-Threonine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proteoglycans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Transforming Growth Factor-beta Type II", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Transforming Growth Factor beta", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transforming Growth Factor beta", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.176731.5", 
          "name": [
            "Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Copland", 
        "givenName": "John A", 
        "id": "sg:person.01037001241.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037001241.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bioinformatics Program, University of Texas Medical Branch, 77555, Galveston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.176731.5", 
          "name": [
            "Bioinformatics Program, University of Texas Medical Branch, 77555, Galveston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luxon", 
        "givenName": "Bruce A", 
        "id": "sg:person.01171172427.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171172427.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ajani", 
        "givenName": "Laila", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maity", 
        "givenName": "Tapati", 
        "id": "sg:person.01121000551.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121000551.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.176731.5", 
          "name": [
            "Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campagnaro", 
        "givenName": "Erica", 
        "id": "sg:person.01153237036.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153237036.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, 77555, Galveston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.176731.5", 
          "name": [
            "Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, 77555, Galveston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guo", 
        "givenName": "Huiping", 
        "id": "sg:person.01046261634.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046261634.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.176731.5", 
          "name": [
            "Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "LeGrand", 
        "givenName": "Shauna N", 
        "id": "sg:person.01073641510.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073641510.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tamboli", 
        "givenName": "Pheroze", 
        "id": "sg:person.01274763446.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274763446.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wood", 
        "givenName": "Christopher G", 
        "id": "sg:person.01040121722.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ncb826", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031266099", 
          "https://doi.org/10.1038/ncb826"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00240-002-0245-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030540675", 
          "https://doi.org/10.1007/s00240-002-0245-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-09-11", 
    "datePublishedReg": "2003-09-11", 
    "description": "Renal cell carcinoma (RCC) is a major health issue. Whereas localized disease can be cured surgically, there is no effective therapy for metastatic disease. The development of an effective therapy will require an understanding of the pathways that are important in RCC carcinogenesis and progression. Using genomic profiling of patient-matched tissue, we have identified aberrations in the transforming growth factor \u03b2 (TGF\u03b2) signaling pathway in RCC. We observed loss of type III TGF\u03b2 receptor (TBR3) expression in all RCC samples. This suggests that TBR3 loss is an early event in RCC carcinogenesis and plays a sentinel role in the acquisition of a tumorigenic phenotype. We also observed subsequent loss of type II TGF\u03b2 receptor (TBR2) expression in metastatic RCCs. We propose that loss of TBR3 is necessary for RCC carcinogenesis, and that loss of TBR2 leads to acquisition of a metastatic phenotype. To this end, we have identified a human renal cell carcinoma line (UMRC6) that is representative of localized, nonmetastatic RCC, reflecting a loss of TBR3, but not TBR2 expression. Another cell line, UMRC3, is highly metastatic, having lost TBR3 and TBR2 expression. We demonstrate functional loss of TGF\u03b2 responsiveness in these cell lines as observed through phenotypic and transcriptional responsiveness to exogenous TGF\u03b2. Restoring TBR2 and TBR3 expression in UMRC3 cells attenuates cell proliferation, completely restores TGF\u03b2-mediated transcriptional responses, and completely blocks anchorage independent-growth: while restoration of TBR2 partially restores TGF\u03b2-mediated signaling. Based on these data, we propose that dysregulation in TGF\u03b2 signaling, through stepwise loss in receptor expression, plays a prominent role in RCC carcinogenesis and progression. In addition, these studies unequivocably demonstrate a link between loss of TBR3 and a human disease.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1206835", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "39", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "renal cell carcinoma", 
      "receptor expression", 
      "RCC carcinogenesis", 
      "TGF\u03b2 receptor expression", 
      "effective therapy", 
      "metastatic renal cell carcinoma", 
      "nonmetastatic renal cell carcinoma", 
      "renal cell carcinoma lines", 
      "human renal cell carcinoma lines", 
      "major health issue", 
      "cell lines", 
      "attenuates cell proliferation", 
      "growth factor \u03b2", 
      "metastatic disease", 
      "cell carcinoma", 
      "exogenous TGF\u03b2", 
      "TGF\u03b2 responsiveness", 
      "renal cell carcinogenesis", 
      "Tbr2 expression", 
      "cell carcinogenesis", 
      "carcinoma lines", 
      "functional loss", 
      "genomic profiling", 
      "sentinel role", 
      "health issues", 
      "RCC samples", 
      "metastatic phenotype", 
      "carcinogenesis", 
      "disease", 
      "cell proliferation", 
      "progression", 
      "Tbr2", 
      "TGF\u03b2", 
      "factor \u03b2", 
      "type III", 
      "therapy", 
      "early events", 
      "tumorigenic phenotype", 
      "human diseases", 
      "expression", 
      "responsiveness", 
      "phenotype", 
      "subsequent loss", 
      "carcinoma", 
      "transcriptional responsiveness", 
      "pathway", 
      "transcriptional response", 
      "dysregulation", 
      "loss", 
      "prominent role", 
      "tissue", 
      "proliferation", 
      "alterations", 
      "role", 
      "signaling", 
      "aberrations", 
      "lines", 
      "response", 
      "restoration", 
      "study", 
      "TBR3", 
      "phenotypic", 
      "profiling", 
      "events", 
      "acquisition", 
      "stepwise loss", 
      "samples", 
      "data", 
      "addition", 
      "development", 
      "end", 
      "understanding", 
      "block", 
      "link", 
      "issues"
    ], 
    "name": "Genomic profiling identifies alterations in TGF\u03b2 signaling through loss of TGF\u03b2 receptor expression in human renal cell carcinogenesis and progression", 
    "pagination": "8053-8062", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008229281"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1206835"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12970754"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1206835", 
      "https://app.dimensions.ai/details/publication/pub.1008229281"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_376.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1206835"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206835'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206835'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206835'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206835'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      117 URIs      107 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1206835 schema:about N0895c9cdbf7d4c59a520c0d0279a9417
2 N16351f0f2baf4d63a81427fc49a2b955
3 N1dac4b37f1e340aab168a7ea82989593
4 N1f5518221f79445f9c85ac76db20674c
5 N58558d2bc3974dd389174ad03f50f908
6 N639384af15474203a080d9018431f102
7 N6b2500f2ae0a417f8bd8720c7cd757e8
8 N7073483ac96b45998229c96630fb5de1
9 N83ac97256bdb4d959063d41e03699f7c
10 N8985c673456247dcaa60e24772a9836c
11 Na5a77234598449c787fb4734db33a31c
12 Na7a578cd45a64cf29090a9b0d91919ab
13 Nab95cdf3b99c4a3ca18fbe8fced7384a
14 Nb5cb3dce508e4437807c3d0dd93ebc25
15 Nf2642fd12ab24a23ad1a360f64dae2d4
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author Nfdb11fccbfaf4b358092339ce6fdbec2
19 schema:citation sg:pub.10.1007/s00240-002-0245-6
20 sg:pub.10.1038/ncb826
21 schema:datePublished 2003-09-11
22 schema:datePublishedReg 2003-09-11
23 schema:description Renal cell carcinoma (RCC) is a major health issue. Whereas localized disease can be cured surgically, there is no effective therapy for metastatic disease. The development of an effective therapy will require an understanding of the pathways that are important in RCC carcinogenesis and progression. Using genomic profiling of patient-matched tissue, we have identified aberrations in the transforming growth factor β (TGFβ) signaling pathway in RCC. We observed loss of type III TGFβ receptor (TBR3) expression in all RCC samples. This suggests that TBR3 loss is an early event in RCC carcinogenesis and plays a sentinel role in the acquisition of a tumorigenic phenotype. We also observed subsequent loss of type II TGFβ receptor (TBR2) expression in metastatic RCCs. We propose that loss of TBR3 is necessary for RCC carcinogenesis, and that loss of TBR2 leads to acquisition of a metastatic phenotype. To this end, we have identified a human renal cell carcinoma line (UMRC6) that is representative of localized, nonmetastatic RCC, reflecting a loss of TBR3, but not TBR2 expression. Another cell line, UMRC3, is highly metastatic, having lost TBR3 and TBR2 expression. We demonstrate functional loss of TGFβ responsiveness in these cell lines as observed through phenotypic and transcriptional responsiveness to exogenous TGFβ. Restoring TBR2 and TBR3 expression in UMRC3 cells attenuates cell proliferation, completely restores TGFβ-mediated transcriptional responses, and completely blocks anchorage independent-growth: while restoration of TBR2 partially restores TGFβ-mediated signaling. Based on these data, we propose that dysregulation in TGFβ signaling, through stepwise loss in receptor expression, plays a prominent role in RCC carcinogenesis and progression. In addition, these studies unequivocably demonstrate a link between loss of TBR3 and a human disease.
24 schema:genre article
25 schema:isAccessibleForFree false
26 schema:isPartOf N06a56eef02e34ff09c356153a8aac8b9
27 N9b7892febee348128049d270b1ee6dbc
28 sg:journal.1097543
29 schema:keywords RCC carcinogenesis
30 RCC samples
31 TBR3
32 TGFβ
33 TGFβ receptor expression
34 TGFβ responsiveness
35 Tbr2
36 Tbr2 expression
37 aberrations
38 acquisition
39 addition
40 alterations
41 attenuates cell proliferation
42 block
43 carcinogenesis
44 carcinoma
45 carcinoma lines
46 cell carcinogenesis
47 cell carcinoma
48 cell lines
49 cell proliferation
50 data
51 development
52 disease
53 dysregulation
54 early events
55 effective therapy
56 end
57 events
58 exogenous TGFβ
59 expression
60 factor β
61 functional loss
62 genomic profiling
63 growth factor β
64 health issues
65 human diseases
66 human renal cell carcinoma lines
67 issues
68 lines
69 link
70 loss
71 major health issue
72 metastatic disease
73 metastatic phenotype
74 metastatic renal cell carcinoma
75 nonmetastatic renal cell carcinoma
76 pathway
77 phenotype
78 phenotypic
79 profiling
80 progression
81 proliferation
82 prominent role
83 receptor expression
84 renal cell carcinogenesis
85 renal cell carcinoma
86 renal cell carcinoma lines
87 response
88 responsiveness
89 restoration
90 role
91 samples
92 sentinel role
93 signaling
94 stepwise loss
95 study
96 subsequent loss
97 therapy
98 tissue
99 transcriptional response
100 transcriptional responsiveness
101 tumorigenic phenotype
102 type III
103 understanding
104 schema:name Genomic profiling identifies alterations in TGFβ signaling through loss of TGFβ receptor expression in human renal cell carcinogenesis and progression
105 schema:pagination 8053-8062
106 schema:productId Nb94ae96d0e854951b306fbfab3a54f50
107 Nc83e34a8cbfa4837bab7b5f3f99a68f8
108 Ne9ed0f49366b4efabcb5c41a44885c7b
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008229281
110 https://doi.org/10.1038/sj.onc.1206835
111 schema:sdDatePublished 2022-09-02T15:50
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher Nac6de7cbd60a4f6c99ffd30075f4021f
114 schema:url https://doi.org/10.1038/sj.onc.1206835
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N06a56eef02e34ff09c356153a8aac8b9 schema:volumeNumber 22
119 rdf:type schema:PublicationVolume
120 N0895c9cdbf7d4c59a520c0d0279a9417 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Gene Expression Regulation, Neoplastic
122 rdf:type schema:DefinedTerm
123 N0b87b5d5985848e18922404b6d99afc1 rdf:first sg:person.01274763446.75
124 rdf:rest N70edf57d49034134918431503e95c672
125 N16351f0f2baf4d63a81427fc49a2b955 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Cell Division
127 rdf:type schema:DefinedTerm
128 N1dac4b37f1e340aab168a7ea82989593 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Tumor Cells, Cultured
130 rdf:type schema:DefinedTerm
131 N1f5518221f79445f9c85ac76db20674c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Receptors, Transforming Growth Factor beta
133 rdf:type schema:DefinedTerm
134 N36447a6a14574f51835a249a5954bc0a rdf:first sg:person.01153237036.08
135 rdf:rest Nc04417ab25d646909f9a6fe5458e1fc9
136 N58558d2bc3974dd389174ad03f50f908 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Carcinoma, Renal Cell
138 rdf:type schema:DefinedTerm
139 N639384af15474203a080d9018431f102 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Transforming Growth Factor beta
141 rdf:type schema:DefinedTerm
142 N6b2500f2ae0a417f8bd8720c7cd757e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Signal Transduction
144 rdf:type schema:DefinedTerm
145 N7073483ac96b45998229c96630fb5de1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Receptor, Transforming Growth Factor-beta Type II
147 rdf:type schema:DefinedTerm
148 N70edf57d49034134918431503e95c672 rdf:first sg:person.01040121722.56
149 rdf:rest rdf:nil
150 N75c64089026742bda372a4b3f9139a44 schema:affiliation grid-institutes:grid.240145.6
151 schema:familyName Ajani
152 schema:givenName Laila
153 rdf:type schema:Person
154 N83ac97256bdb4d959063d41e03699f7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Humans
156 rdf:type schema:DefinedTerm
157 N8985c673456247dcaa60e24772a9836c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Kidney Neoplasms
159 rdf:type schema:DefinedTerm
160 N9b7892febee348128049d270b1ee6dbc schema:issueNumber 39
161 rdf:type schema:PublicationIssue
162 Na280784b910d4787a3a1af711a3e6ff6 rdf:first sg:person.01073641510.05
163 rdf:rest N0b87b5d5985848e18922404b6d99afc1
164 Na5a77234598449c787fb4734db33a31c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Proteoglycans
166 rdf:type schema:DefinedTerm
167 Na7a578cd45a64cf29090a9b0d91919ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Protein Serine-Threonine Kinases
169 rdf:type schema:DefinedTerm
170 Nab95cdf3b99c4a3ca18fbe8fced7384a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Disease Progression
172 rdf:type schema:DefinedTerm
173 Nac6de7cbd60a4f6c99ffd30075f4021f schema:name Springer Nature - SN SciGraph project
174 rdf:type schema:Organization
175 Nb5cb3dce508e4437807c3d0dd93ebc25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Gene Expression Profiling
177 rdf:type schema:DefinedTerm
178 Nb94ae96d0e854951b306fbfab3a54f50 schema:name dimensions_id
179 schema:value pub.1008229281
180 rdf:type schema:PropertyValue
181 Nc04417ab25d646909f9a6fe5458e1fc9 rdf:first sg:person.01046261634.46
182 rdf:rest Na280784b910d4787a3a1af711a3e6ff6
183 Nc83e34a8cbfa4837bab7b5f3f99a68f8 schema:name doi
184 schema:value 10.1038/sj.onc.1206835
185 rdf:type schema:PropertyValue
186 Nd88294f8b3e0447991e6312cc4d54a8f rdf:first sg:person.01121000551.13
187 rdf:rest N36447a6a14574f51835a249a5954bc0a
188 Ne818186d1a104d33ad1f33d5a2a38d5f rdf:first sg:person.01171172427.09
189 rdf:rest Nfab8f4db18a64a04b32b000f18384b0c
190 Ne9ed0f49366b4efabcb5c41a44885c7b schema:name pubmed_id
191 schema:value 12970754
192 rdf:type schema:PropertyValue
193 Nf2642fd12ab24a23ad1a360f64dae2d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Polymerase Chain Reaction
195 rdf:type schema:DefinedTerm
196 Nfab8f4db18a64a04b32b000f18384b0c rdf:first N75c64089026742bda372a4b3f9139a44
197 rdf:rest Nd88294f8b3e0447991e6312cc4d54a8f
198 Nfdb11fccbfaf4b358092339ce6fdbec2 rdf:first sg:person.01037001241.67
199 rdf:rest Ne818186d1a104d33ad1f33d5a2a38d5f
200 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
201 schema:name Medical and Health Sciences
202 rdf:type schema:DefinedTerm
203 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
204 schema:name Clinical Sciences
205 rdf:type schema:DefinedTerm
206 sg:journal.1097543 schema:issn 0950-9232
207 1476-5594
208 schema:name Oncogene
209 schema:publisher Springer Nature
210 rdf:type schema:Periodical
211 sg:person.01037001241.67 schema:affiliation grid-institutes:grid.176731.5
212 schema:familyName Copland
213 schema:givenName John A
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037001241.67
215 rdf:type schema:Person
216 sg:person.01040121722.56 schema:affiliation grid-institutes:grid.240145.6
217 schema:familyName Wood
218 schema:givenName Christopher G
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56
220 rdf:type schema:Person
221 sg:person.01046261634.46 schema:affiliation grid-institutes:grid.176731.5
222 schema:familyName Guo
223 schema:givenName Huiping
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046261634.46
225 rdf:type schema:Person
226 sg:person.01073641510.05 schema:affiliation grid-institutes:grid.176731.5
227 schema:familyName LeGrand
228 schema:givenName Shauna N
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073641510.05
230 rdf:type schema:Person
231 sg:person.01121000551.13 schema:affiliation grid-institutes:grid.240145.6
232 schema:familyName Maity
233 schema:givenName Tapati
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121000551.13
235 rdf:type schema:Person
236 sg:person.01153237036.08 schema:affiliation grid-institutes:grid.176731.5
237 schema:familyName Campagnaro
238 schema:givenName Erica
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153237036.08
240 rdf:type schema:Person
241 sg:person.01171172427.09 schema:affiliation grid-institutes:grid.176731.5
242 schema:familyName Luxon
243 schema:givenName Bruce A
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171172427.09
245 rdf:type schema:Person
246 sg:person.01274763446.75 schema:affiliation grid-institutes:grid.240145.6
247 schema:familyName Tamboli
248 schema:givenName Pheroze
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274763446.75
250 rdf:type schema:Person
251 sg:pub.10.1007/s00240-002-0245-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030540675
252 https://doi.org/10.1007/s00240-002-0245-6
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/ncb826 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031266099
255 https://doi.org/10.1038/ncb826
256 rdf:type schema:CreativeWork
257 grid-institutes:grid.176731.5 schema:alternateName Bioinformatics Program, University of Texas Medical Branch, 77555, Galveston, TX, USA
258 Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA
259 Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, 77555, Galveston, TX, USA
260 schema:name Bioinformatics Program, University of Texas Medical Branch, 77555, Galveston, TX, USA
261 Endocrinology Division, Internal Medicine Department, University of Texas Medical Branch, 77555, Galveston, TX, USA
262 Sealy Center for Cancer Cell Biology, University of Texas Medical Branch, 77555, Galveston, TX, USA
263 rdf:type schema:Organization
264 grid-institutes:grid.240145.6 schema:alternateName Department of Pathology, University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA
265 Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA
266 schema:name Department of Pathology, University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA
267 Department of Urology and Cancer Biology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...